Mark Robert Baker is CEO at PROGENICS PHARMACEUTICALS INC (PGNX). They have made 4 open-market trades across 1 company since 2010, most recently 2013-03-27.
CIK 0001331438
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $276K since 2011, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PGNX | 161,041 | $660K |
Shares reported on the most recent Form 4, priced at the 2013-03-28 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PGNX | BUY | 2013-03-27 | 2013-03-28 | $5.32 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2013-02-27 | 2013-02-28 | $2.72 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2013-01-22 | 2013-01-23 | $2.82 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-12-26 | 2012-12-26 | $3.01 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-11-28 | 2012-11-30 | $2.13 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-11-19 | 2012-11-20 | $1.96 | $23K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-11-16 | 2012-11-19 | $1.82 | $91K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-11-15 | 2012-11-16 | $1.69 | $83K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-10-24 | 2012-10-25 | $2.96 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-09-26 | 2012-09-27 | $3.32 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-08-22 | 2012-08-23 | $4.23 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-07-25 | 2012-07-26 | $10.04 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-06-27 | 2012-06-29 | $9.27 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-05-23 | 2012-05-24 | $7.81 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-04-25 | 2012-04-27 | $10.07 | $4K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-03-28 | 2012-03-29 | $10.13 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-02-22 | 2012-02-23 | $9.41 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2012-01-25 | 2012-01-26 | $9.53 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | SELL · 10b5-1 | 2011-11-23 | 2011-11-28 | $5.45 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2011-10-26 | 2012-01-12 | $7.51 | $7K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2011-09-28 | 2011-09-28 | $6.39 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2011-08-24 | 2011-08-25 | $6.08 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2011-07-27 | 2011-07-28 | $6.12 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2011-06-22 | 2011-06-24 | $7.08 | $3K | -27.5% | -3.2% | -3.2% |
| PGNX | BUY | 2011-05-25 | 2011-05-26 | $7.13 | $3K | -27.5% | -3.2% | -3.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.